Financhill
Back

Cardiff Oncology Stock Predictions

Cardiff Oncology Stock Forecast

  • Is Cardiff Oncology Stock Undervalued?
    The current Cardiff Oncology [CRDF] share price is $3.52. The Score for CRDF is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • CRDF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Cardiff Oncology Stock Go Up Next Year?

Data Unavailable

Cardiff Oncology Stock Rating

Data Unavailable

Cardiff Oncology Stock Price History

Is CRDF stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRDF is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cardiffoncology.com

52-Week Data

52-Week High:
6.42
52-Week Low:
0.94

Prediction Charts

Market Cap:
157.26M
Price in USD:
3.52
Volume:
2.14M
Beta:
0.89

Technical Analysis

SMA50:
4.49
SMA100:
3.03
SMA200:
2.24
52-Wk Change:
89.25%

Stock Predictions

  • Is Cardiff Oncology stock public?
    Yes, Cardiff Oncology is a publicly traded company.
  • What is the Cardiff Oncology stock quote today?
    The Cardiff Oncology stock price is 3.52 USD today.
  • How to buy Cardiff Oncology stock online?
    You can buy Cardiff Oncology shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-16 5.25 4.58 5.25 4.20
Apr-17 4.57 4.51 4.86 4.32
Apr-18 4.43 4.35 4.48 4.26
Apr-19 4.38 4.33 4.57 4.26
Apr-22 4.26 4.36 4.49 4.25
Apr-23 4.36 4.17 4.42 4.06
Apr-24 4.17 4.18 4.38 4.09
Apr-25 4.12 3.99 4.20 3.95
Apr-26 4.06 4.07 4.13 3.98
Apr-29 4.14 4.46 4.68 4.12
Apr-30 4.50 4.35 4.54 4.26
May-1 4.38 4.23 4.45 4.15
May-2 4.25 4.47 4.50 4.07
May-3 3.98 3.52 4.42 3.12

Cardiff Oncology Earnings

Data Unavailable

Cardiff Oncology Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.02 per share, and a decrease next year of $0.15 per share.

* Cardiff Oncology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.